跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
陳 冠州
教授
,
臨床醫學研究所
合聘教授
,
泌尿學科
主治醫師
,
衛生福利部雙和醫院
成員
,
臺北醫學大學泌尿腎臟研究中心
https://orcid.org/0000-0002-0049-1685
電子郵件
kuanchou
s.tmu.edu
tw
h-index
1943
引文
26
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1994 …
2024
每年研究成果
概覽
指紋
網路
專案
(17)
研究成果
(143)
資料集
(1)
類似的個人檔案
(6)
指紋
查看啟用 Kuan-Chou Chen 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Chronic Kidney Failure
64%
Androgen
53%
Antioxidant
46%
Bladder Cancer
45%
Quercetin
45%
Guava
40%
Neoplasm
38%
Gallic Acid
37%
Polysaccharide
34%
Castration Resistant Prostate Cancer
33%
Malignant Neoplasm
32%
Ferulic Acid
32%
Bicalutamide
32%
Prostate Hypertrophy
32%
Antrodia camphorata
32%
Rat Model
28%
Kidney Injury
28%
Doxorubicin
27%
Cancer Growth
27%
Sodium Valproate
26%
Reactive Oxygen Metabolite
24%
Uropathogenic Escherichia Coli
24%
Nifedipine
24%
Pummelo
24%
Hypolipemia
24%
Rutin
22%
Anti-Inflammatory Drug
22%
Prostate Specific Antigen
22%
Teratogenicity
21%
Therapeutic Effect
20%
Lipotoxicity
20%
Transitional Cell Carcinoma
20%
Essential Oil
19%
Homocysteine
18%
Caspase 3
18%
Triacylglycerol
18%
Infection
18%
Polyphenol
18%
Diabetes Mellitus
17%
Sterol Regulatory Element Binding Protein
17%
Cytotoxicity
17%
Metalloproteinase
16%
Disintegrin
16%
Mouse
16%
Bone Injury
16%
Insulin Dependent Diabetes Mellitus
16%
Rabbit Model
16%
Leporidae
16%
Antiinfective Agent
16%
Medicine and Dentistry
Prostate Cancer
64%
Chronic Kidney Disease
39%
Neoplasm
32%
Urinary System
30%
Androgen
27%
Malignant Neoplasm
26%
Cancer Growth
26%
Signal Transduction
26%
Bladder Cancer
25%
Prostate Hypertrophy
25%
Bladder
24%
Systematic Review
24%
Meta-Analysis
24%
Uropathogenic Escherichia Coli
24%
Nifedipine
24%
Percutaneous Nephrolithotomy
24%
Bicalutamide
24%
Diabetes
24%
In Vitro
23%
Transitional Cell Carcinoma
23%
Carcinoma
21%
Cancer Cell
20%
Symptom
19%
Kidney Injury
19%
down Regulation
19%
Metastatic Carcinoma
18%
Infection
18%
Diabetes Mellitus
17%
Cystectomy
17%
Autophagy
16%
Small-Cell Carcinoma
16%
Sterol Regulatory Element Binding Protein
16%
Hemodialysis
16%
Vasectomy
16%
Lymphoepithelioma
16%
Stromelysin
16%
Knee Joint
16%
Prostate Cell
16%
Castration Resistant Prostate Cancer
16%
Bone Injury
16%
Cardiovascular Disease
16%
Lipogenesis
16%
Cell Death
16%
Randomized Clinical Trial
16%
Disease
14%
Cell Proliferation
14%
Recurrent Disease
14%
Stent Placement
14%
Cell Line
13%
Transurethral Resection
13%
Biochemistry, Genetics and Molecular Biology
Quercetin
29%
Cancer Cell
28%
Gallic Acid
25%
Uropathogenic Escherichia Coli
24%
Nifedipine
24%
Doxorubicin
23%
Biological Activity
22%
Signal Transduction
21%
Lipotoxicity
20%
Chorioallantoic Membrane Assay
20%
Ferulic Acid
20%
Polysaccharide
18%
Sterol Regulatory Element-Binding Protein
17%
Psidium
17%
Upregulation
16%
Retention Time
16%
Hemodialysis
16%
Facilitated Diffusion
16%
Antrodia camphorata
16%
Matrix Metalloproteinase
16%
STAT3
16%
Lipogenesis
16%
Animal Model
16%
ADAM9
16%
Bicalutamide
16%
AMP-activated Protein Kinase
13%
Rutin
12%
Lipid Storage
12%
Rat Model
12%
Hesperidin
12%
IC50
12%
Insulin Release
12%
STAT1
11%
Interleukin-6
10%
Antiangiogenic Activity
10%
Angiogenesis
10%
Absorption
10%
down Regulation
10%
Fibroblast
10%
P21
10%
Prostate-Specific Antigen
10%
Exercise
10%
Low-Density Lipoprotein
10%
Genetics
9%
Vascular Endothelial Growth Factor
9%
Homocysteine
9%
CD36
9%
Cell Migration
9%
Hydrogen Peroxide
9%
Western Blot
9%
